Core Insights - Borregaard ASA has seen several primary insiders exercise stock options at a strike price of NOK 164.45 per share on 16.02.2026, indicating active management participation in the company's equity [1][2][3]. Group 1: Insider Transactions - Tom Erik Foss-Jacobsen exercised 15,000 options and now holds 93,000 options and 31,875 shares [1] - Per Bjarne Lyngstad exercised 10,000 options and now holds 47,000 options and 63,056 shares [1] - Gisle Løhre Johansen exercised 10,000 options and now holds 47,000 options and 22,475 shares [1] - Kristin Misund exercised 8,000 options and now holds 39,500 options and 70,223 shares [1] - Liv Longva exercised 8,000 options and now holds 39,500 options and 13,539 shares [1] - Dag Arthur Aasbø exercised 8,000 options and now holds 39,500 options and 57,356 shares [1] - Pål Espen Ramberg exercised 6,000 options, purchased 6,000 shares, and sold 5,914 shares, now holding 26,500 options and 13,439 shares [1] - Sveinung Heggen exercised 8,000 options, purchased 8,000 shares, and sold 7,600 shares, now holding 39,500 options and 27,864 shares [2] - Ole Gunnar Jakobsen exercised 10,000 options, purchased 10,000 shares, and sold 9,714 shares, now holding 47,000 options and 34,909 shares [3] Group 2: Share Options Overview - The share options were issued on 16.02.2021, with the last possible exercise date being 16.02.2026 [4] - The total number of outstanding share options is 1,264,500, which is equivalent to 1.3% of the total number of shares, including 268,893 treasury shares [4]

Core Viewpoint - Borregaard ASA is offering its employees the opportunity to purchase shares at a discounted price, which is a strategic move to enhance employee engagement and investment in the company [1] Employee Share Purchase Program - The share purchase program is valid from 9 February to 13 February 2026 [1] - Employees can buy shares at a price equal to the average volume weighted market price on 13 February 2026, with a 25% discount applied [1] - The total amount employees may invest in shares is set at NOK 5,000, NOK 15,000, NOK 25,000, NOK 40,000, NOK 60,000, or NOK 78,000 [1]

Core Insights - Borregaard's operating revenues for Q4 2025 reached NOK 1,833 million, an increase from NOK 1,744 million in Q4 2024, while EBITDA rose to NOK 405 million from NOK 398 million [1] - The company reported a total impairment of NOK 245 million on investments in bio-based start-ups, leading to a profit before tax of NOK -28 million compared to NOK 170 million in the previous year [3] - For the full year 2025, operating revenues increased to NOK 7,713 million from NOK 7,617 million, with EBITDA at an all-time high of NOK 1,878 million, despite a decrease in Fine Chemicals results [4][5] Financial Performance - In Q4 2025, BioSolutions experienced high deliveries of biovanillin and growth in agricultural sales, but this was offset by increased costs [2] - BioMaterials benefited from higher sales prices and lower wood and energy costs, which compensated for other cost increases [2] - Fine Chemicals faced lower bioethanol sales prices, although strong results in fine chemical intermediates provided some offset [2] Impairments and Earnings - The impairment of NOK 245 million reflects recent developments in bio-based start-ups Alginor ASA, Kaffe Bueno ApS, and Lignovations GmbH [3] - Earnings per share for Q4 2025 were NOK -0.81, down from NOK 1.30 in Q4 2024; excluding impairments, earnings per share were NOK 1.64 [3] - For the full year 2025, earnings per share were NOK 6.22, down from NOK 8.25 in 2024; excluding impairments, earnings per share were NOK 8.67 [4]

Group 1 - Borregaard ASA will report its fourth quarter 2025 results on February 4, 2026, at 07:00 CET, with a stock exchange announcement to follow [1] - A presentation of the results will take place at 08:30 CET at Pareto Securities AS in Oslo, and it will be available for live streaming on the company's website [2] - The presentations will be conducted in English, and attendees will have the opportunity to ask questions via the web [2] Group 2 - For further inquiries, Lotte Kvinlaug serves as the Investor Relations Officer and can be contacted at +47 922 86 909 [3] - The information provided is subject to the disclosure requirements under the Norwegian Securities Trading Act and the EU Market Abuse Regulation [3]

Group 1 - The company expects Q4 sales volume in BioSolutions to be between 70,000 and 75,000 tonnes, which is a decrease from 77,000 tonnes in the same quarter last year [2] - There is an anticipated positive but limited effect from antidumping duties on vending [3] - Margin development in BioSolutions has shown a year-on-year decline, which was a core question raised during the Q&A session [3]

Core Viewpoint - The article emphasizes the importance of enabling Javascript and cookies in browsers to prevent access issues, particularly when ad-blockers are enabled [1] Group 1 - The article suggests that users may face restrictions if they have ad-blockers enabled, indicating a need for adjustments in browser settings to ensure smooth access [1]

Core Insights - Borregaard's operating revenues for Q3 2025 were NOK 1,799 million, a decrease from NOK 1,949 million in Q3 2024 [1] - EBITDA fell to NOK 440 million from NOK 524 million year-over-year [1] - Profit before tax decreased to NOK 247 million from NOK 326 million, and earnings per share dropped to NOK 1.96 from NOK 2.51 [3] Revenue and Performance Analysis - The decline in EBITDA was attributed to lower bioethanol prices and a temporary disruption in cellulose production at the Sarpsborg site, which had an estimated negative impact of NOK 40 million [2] - BioSolutions experienced growth in sales to agriculture, contributing positively to the overall results [2] - In BioMaterials, higher sales prices were offset by lower sales volume, while Fine Chemicals showed strong performance [2] Management Commentary - The CEO, Tom Erik Foss-Jacobsen, expressed satisfaction with the strong agricultural sales and the company's ability to deliver solid results amid uncertain global conditions, highlighting the strength and flexibility of Borregaard's business model [3]

Core Viewpoint - Borregaard ASA is set to report its third quarter 2025 results on October 22, 2025, at 07:00 CEST, with a stock exchange announcement to follow [1] Group 1: Financial Reporting - The third quarter 2025 results will be presented at 08:30 CEST at ABG Sundal Collier in Oslo, with options for in-person attendance and live streaming available [2] - A press release, quarterly report, and presentation will be accessible on Borregaard's investor website [1] Group 2: Investor Relations - Questions can be submitted via the web during the live presentation, which will be conducted in English [2] - For further inquiries, Lotte Kvinlaug serves as the Investor Relations Officer, reachable at +47 922 86 909 [3]

Group 1 - Borregaard, along with shareholders Must Invest and Hatteland Group, will guarantee a NOK 200 million convertible loan to Alginor, which can be converted into new shares at a subscription price of NOK 10 per share [1] - All shareholders of Alginor are invited to participate in the convertible loan, with Borregaard's share ranging from NOK 83 to 111 million, to be paid in two equal tranches in October 2025 and February 2026 [2] - The financing solution includes an additional uncommitted tap facility of NOK 100 million and a secured loan facility of NOK 230 million from Haugesund Sparebank [2][3] Group 2 - The combined financing is expected to be sufficient for completing and commissioning a commercial-scale demonstration plant for alginates [3]

Core Insights - The Norwegian Research Council has awarded NOK 15 million to Borregaard for its Biomer innovation initiative aimed at developing bio-based alternatives to polycarboxylates [1][3] - Polycarboxylates are fossil-based polymers with a high carbon footprint and environmental persistence, which Borregaard seeks to replace with greener alternatives [2] - The Biomer project will utilize Borregaard's advanced biorefinery and expertise in wood chemistry to create sustainable solutions with a significantly lower environmental impact [2] Project Details - The Biomer project is set to run for four years, from January 2026 to December 2029 [3] - The initiative aims to create new high-value markets for Norwegian bioresources and contribute to reducing the carbon footprint across various sectors [3]